DE69327248T2 - Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium - Google Patents

Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium

Info

Publication number
DE69327248T2
DE69327248T2 DE69327248T DE69327248T DE69327248T2 DE 69327248 T2 DE69327248 T2 DE 69327248T2 DE 69327248 T DE69327248 T DE 69327248T DE 69327248 T DE69327248 T DE 69327248T DE 69327248 T2 DE69327248 T2 DE 69327248T2
Authority
DE
Germany
Prior art keywords
vitamin
calcium
treating
premium
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327248T
Other languages
English (en)
Other versions
DE69327248D1 (de
Inventor
Susan Thys-Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THYS JACOBS SUSAN
Original Assignee
THYS JACOBS SUSAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/945,319 external-priority patent/US5354743A/en
Application filed by THYS JACOBS SUSAN filed Critical THYS JACOBS SUSAN
Application granted granted Critical
Publication of DE69327248D1 publication Critical patent/DE69327248D1/de
Publication of DE69327248T2 publication Critical patent/DE69327248T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69327248T 1992-09-15 1993-09-14 Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium Expired - Fee Related DE69327248T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/945,319 US5354743A (en) 1992-09-15 1992-09-15 Method for the treatment of premenstrual syndrome with vitamin D
US08/059,682 US6228849B1 (en) 1992-09-15 1993-05-10 Method for treating symptoms associated with premenstrual syndrome by administering a combination of calcium and vitamin D
PCT/US1993/008653 WO1994006435A1 (en) 1992-09-15 1993-09-14 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium

Publications (2)

Publication Number Publication Date
DE69327248D1 DE69327248D1 (de) 2000-01-13
DE69327248T2 true DE69327248T2 (de) 2000-07-06

Family

ID=26739051

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327248T Expired - Fee Related DE69327248T2 (de) 1992-09-15 1993-09-14 Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium

Country Status (8)

Country Link
US (1) US5443850A (de)
EP (1) EP0660718B1 (de)
JP (1) JP3676805B2 (de)
AT (1) ATE187332T1 (de)
CA (1) CA2144728C (de)
DE (1) DE69327248T2 (de)
ES (1) ES2139674T3 (de)
WO (1) WO1994006435A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
DE19844836A1 (de) * 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
AU772384B2 (en) * 2001-05-09 2004-04-29 Nestec S.A. Vitex agnus castus extract
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
EP1945185B1 (de) * 2005-10-12 2016-02-03 Proventiv Therapeutics, LLC Verfahren und artikel zur behandlung von 25-hydroxyvitamin-d-insuffizienz und mangel
US20070098819A1 (en) * 2005-11-02 2007-05-03 Susan Thys-Jacobs Micronutrient supplement with calcium, vitamin D or calcium & vitamin D combination for premenstrual syndrome, postpartum depression, depression and panic attacks
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
KR101579631B1 (ko) * 2008-02-13 2015-12-22 디에스엠 아이피 어셋츠 비.브이. 25-하이드록시비타민 ｄ3에 의한 고혈당증 치료
JP6095891B2 (ja) * 2008-07-24 2017-03-15 ウイスコンシン アラムナイ リサーチ ファウンデーシヨンＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ ２５−ヒドロキシビタミンｄ３を含む経口剤形、及び、その経口剤形を週１回ヒトに投与することを含む方法
CA2823974A1 (en) * 2010-01-08 2011-07-14 Beth Israel Deaconess Medical Center Methods and compositions for the treatment of migraine headaches
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
JPS59120078A (ja) * 1982-12-28 1984-07-11 Norio Someya 健康増進剤
US4501738A (en) * 1983-06-30 1985-02-26 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
US4806354A (en) * 1984-04-06 1989-02-21 Green James P Health food composition
CA1250525A (en) * 1985-01-03 1989-02-28 Larry Barron Composition for the relief of menstrual symptoms
US4812303A (en) * 1986-04-03 1989-03-14 Copley Pharmaceuticals, Inc. High dose calcium tablet
US4946679A (en) * 1988-07-25 1990-08-07 Thys Jacobs Susan Method for the treatment of premenstrual syndrome
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid

Also Published As

Publication number Publication date
EP0660718A1 (de) 1995-07-05
CA2144728C (en) 2005-04-26
EP0660718A4 (de) 1997-05-21
CA2144728A1 (en) 1994-03-31
EP0660718B1 (de) 1999-12-08
ES2139674T3 (es) 2000-02-16
JP3676805B2 (ja) 2005-07-27
ATE187332T1 (de) 1999-12-15
DE69327248D1 (de) 2000-01-13
WO1994006435A1 (en) 1994-03-31
JPH08505122A (ja) 1996-06-04
US5443850A (en) 1995-08-22

Similar Documents

Publication Publication Date Title
DE69327248D1 (de) Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium
DE69032662T2 (de) Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis
ATE196849T1 (de) Verfahren zur behandlung von multiplesklerose
ATE298566T1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
ATE209483T1 (de) Behandlung von multipler sklerose
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE71843T1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
DE69525847T2 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
DE69835823D1 (de) Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
ZA926837B (en) A pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
EP0098431A3 (en) Pharmaceutical composition comprising immune globulin and fibronectin
DE69027220D1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DE3650620D1 (de) Behandlungsverfahren kataboler dysfunktion
DE69333711D1 (de) Compactin zur behandlung von entzündungen
YU49422B (sh) Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću
SE9601395D0 (sv) New therapeutic treatment 1
ATE187648T1 (de) Zusammensetzungen enthaltend lipoprotein- associated-coagulation-inhibitor (laci) zur herstellung eines medikaments zur behandlung von akuten oder chronischen enzündungen
DE69218200D1 (de) Behandlung von leberkrebs
ATE222768T1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
ATE155345T1 (de) Gegengift immunsera
ATE57469T1 (de) Lokale behandlung von hautentzuendungsstoerungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee